ZA937452B - Delayed onset transdermal delivery device - Google Patents

Delayed onset transdermal delivery device

Info

Publication number
ZA937452B
ZA937452B ZA937452A ZA937452A ZA937452B ZA 937452 B ZA937452 B ZA 937452B ZA 937452 A ZA937452 A ZA 937452A ZA 937452 A ZA937452 A ZA 937452A ZA 937452 B ZA937452 B ZA 937452B
Authority
ZA
South Africa
Prior art keywords
delivery device
transdermal delivery
delayed onset
onset
delayed
Prior art date
Application number
ZA937452A
Inventor
Eun Soo Lee
Su Ii Yum
Felix Theeuwes
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of ZA937452B publication Critical patent/ZA937452B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA937452A 1992-10-15 1993-10-07 Delayed onset transdermal delivery device ZA937452B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US96124592A 1992-10-15 1992-10-15

Publications (1)

Publication Number Publication Date
ZA937452B true ZA937452B (en) 1994-06-07

Family

ID=25504235

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA937452A ZA937452B (en) 1992-10-15 1993-10-07 Delayed onset transdermal delivery device

Country Status (3)

Country Link
AU (1) AU5354994A (en)
WO (1) WO1994008572A1 (en)
ZA (1) ZA937452B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69733268T2 (en) * 1996-01-30 2006-01-19 Novagent Oy Composition for the controlled release of a drug in transdermal administration
US6586449B1 (en) * 2002-05-28 2003-07-01 Cambrex Charles City, Inc. Nicotine-containing, controlled release composition and method
WO2005053691A2 (en) * 2003-12-02 2005-06-16 Fertin Pharma A/S Nicotine delivery product and method for producing it
EP1846040A2 (en) * 2005-01-28 2007-10-24 Collegium Pharmaceutical, Inc. Non-ionic non-aqueous vehicles for topical and oral administration of carrier-complexed active agents

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3901248A (en) * 1970-07-22 1975-08-26 Leo Ab Chewable smoking substitute composition
GB1349207A (en) * 1972-01-10 1974-04-03 Galat A Pharmaceutical compositions
GB1462356A (en) * 1973-07-10 1977-01-26 Beecham Group Ltd Pharmaceutical compositions
US4650484A (en) * 1983-02-03 1987-03-17 Alza Corporation Method for treating ischemic conditions
US4692462A (en) * 1985-03-18 1987-09-08 Menley & James Laboratories, Ltd. Compositions and method of controlling transdermal penetration of topical and systemic agents
US4781924A (en) * 1987-11-09 1988-11-01 Alza Corporation Transdermal drug delivery device
PT90820B (en) * 1988-06-14 1995-05-31 Alza Corp SUB-SATURATED TRANSDERMIC LIBRARIAN DEVICE
DE3905051A1 (en) * 1989-02-18 1990-08-30 Lohmann Therapie Syst Lts THERAPEUTIC SYSTEM FOR DELAYED AND CONTROLLED TRANSDERMAL OR TRANSMUCOSAL ADMINISTRATION OF ACTIVE SUBSTANCES (I)

Also Published As

Publication number Publication date
WO1994008572A1 (en) 1994-04-28
AU5354994A (en) 1994-05-09

Similar Documents

Publication Publication Date Title
AU590921B2 (en) Delayed onset transdermal delivery device
GB9218937D0 (en) Medicament dispensing device
GB9211434D0 (en) Medicament dispensing device
GB9211435D0 (en) Medicament dispensing device
HRP931266B1 (en) Securing device
GB9213167D0 (en) Dispensing device
GB9203905D0 (en) Window-breaking device
GB9217715D0 (en) Dispensing device
GB9318603D0 (en) Therapeutic device
IL106930A0 (en) Medicament dispensing device
ZA937452B (en) Delayed onset transdermal delivery device
GB2265571B (en) Blanket-clamping device
GB9218214D0 (en) Discharge device
EP0668759A4 (en) Transdermal delivery of ketorolac.
GB9202205D0 (en) Transdermal delivery device
GB9202190D0 (en) Transdermal delivery device
AP9200394A0 (en) Medicament dispensing device
GB9218118D0 (en) Device
GB9302972D0 (en) Transdermal delivery device
GB9302971D0 (en) Transdermal delivery device
NZ239990A (en) Transdermal delivery device
GB9102034D0 (en) Transdermal delivery device
GB9102033D0 (en) Transdermal delivery device
GB9002190D0 (en) Transdermal delivery device
GB9003589D0 (en) Transdermal delivery device